StockData
CytomX Therapeutics, Inc. logo

CytomX Therapeutics, Inc. (CTMX) stock

CTMXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 8/30
$1.94−0.05 (-2.27%)

Close on Nov 17, 2026Market cap $422.73MP/E –Yield –

CytomX Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

CytomX Therapeutics's market cap was $386.80M on Nov 11, 2026, against $499.61M a year earlier. Over the last 5 years it ranged from $50.93M to $913.90M, with a median of $114.76M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$386.80M-22.2%
2025Dec 31, 2025$497.27M+477.7%
2024Dec 31, 2024$86.08M-20.6%
2023Dec 29, 2023$108.45M+2.8%
2022Dec 30, 2022$105.52M-62.7%
2021Dec 31, 2021$282.53M-6.7%
2020Dec 31, 2020$302.76M-19.8%
2019Dec 31, 2019$377.49M-44.4%
2018Dec 31, 2018$679.46M-13.2%
2017Dec 29, 2017$783.09M+95.8%
2016Dec 30, 2016$399.96M+1650.7%
2015Dec 31, 2015$22.85M–

More CytomX Therapeutics figures

See a number that looks wrong?